Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis

CONCLUSION: T2DM represents a risk factor for the insurgence of pNET and is a significant predictor of poor post-treatment TFS of pNET patients. Unfortunately, a few studies with heterogeneous results limited the possibility of exploring the effect of metformin in the diagnosis and prognosis of pNET.PMID:38515954 | PMC:PMC10950617 | DOI:10.3748/wjg.v30.i7.759
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Source Type: research